PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Mental Health and Clinical Neurosciences Academic Unit, School of Medicine (A.G., N.E.), University of Nottingham; Clinical Neurology (A.G., N.E.), Nottingham University Hospitals NHS Trust; Population Data Science (R.M.M.), Swansea University Medical School; and Department of Cellular and Molecular Neuroscience (R.N.), Imperial College London, United Kingdom.\', \'From the Mental Health and Clinical Neurosciences Academic Unit, School of Medicine (A.G., N.E.), University of Nottingham; Clinical Neurology (A.G., N.E.), Nottingham University Hospitals NHS Trust; Population Data Science (R.M.M.), Swansea University Medical School; and Department of Cellular and Molecular Neuroscience (R.N.), Imperial College London, United Kingdom. nikos.evangelou@nottingham.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • e111810.1212/NXI.0000000000001118
?:doi
?:hasPublicationType
?:journal
  • Neurology(R) neuroimmunology & neuroinflammation
is ?:pmid of
?:pmid
?:pmid
  • 34848503
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all